These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Parasite densities modulate susceptibility of mice to cerebral malaria during co-infection with Schistosoma japonicum and Plasmodium berghei. Wang ML, Feng YH, Pang W, Qi ZM, Zhang Y, Guo YJ, Luo EJ, Cao YM. Malar J; 2014 Mar 26; 13():116. PubMed ID: 24670210 [Abstract] [Full Text] [Related]
5. Eosinophils Suppress the Migration of T Cells Into the Brain of Plasmodium berghei-Infected Ifnar1-/- Mice and Protect Them From Experimental Cerebral Malaria. Scheunemann JF, Reichwald JJ, Korir PJ, Kuehlwein JM, Jenster LM, Hammerschmidt-Kamper C, Lewis MD, Klocke K, Borsche M, Schwendt KE, Soun C, Thiebes S, Limmer A, Engel DR, Mueller AK, Hoerauf A, Hübner MP, Schumak B. Front Immunol; 2021 Mar 26; 12():711876. PubMed ID: 34659202 [Abstract] [Full Text] [Related]
6. Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells. Burrack KS, Huggins MA, Taras E, Dougherty P, Henzler CM, Yang R, Alter S, Jeng EK, Wong HC, Felices M, Cichocki F, Miller JS, Hart GT, Johnson AJ, Jameson SC, Hamilton SE. Immunity; 2018 Apr 17; 48(4):760-772.e4. PubMed ID: 29625893 [Abstract] [Full Text] [Related]
7. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development. Palomo J, Reverchon F, Piotet J, Besnard AG, Couturier-Maillard A, Maillet I, Tefit M, Erard F, Mazier D, Ryffel B, Quesniaux VF. Eur J Immunol; 2015 May 17; 45(5):1354-65. PubMed ID: 25682948 [Abstract] [Full Text] [Related]
8. Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA. Tamura T, Kimura K, Yuda M, Yui K. Infect Immun; 2011 Oct 17; 79(10):3947-56. PubMed ID: 21807908 [Abstract] [Full Text] [Related]
9. Extracellular vesicles derived from plasmodium-infected red blood cells alleviate cerebral malaria in plasmodium berghei ANKA-infected C57BL/6J mice. Lv Y, Wu S, Nie Q, Liu S, Xu W, Chen G, Du Y, Chen J. Int Immunopharmacol; 2024 May 10; 132():111982. PubMed ID: 38569430 [Abstract] [Full Text] [Related]
10. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA. Palomo J, Fauconnier M, Coquard L, Gilles M, Meme S, Szeremeta F, Fick L, Franetich JF, Jacobs M, Togbe D, Beloeil JC, Mazier D, Ryffel B, Quesniaux VF. Eur J Immunol; 2013 Oct 10; 43(10):2683-95. PubMed ID: 23780878 [Abstract] [Full Text] [Related]
11. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria. Oakley MS, Sahu BR, Lotspeich-Cole L, Solanki NR, Majam V, Pham PT, Banerjee R, Kozakai Y, Derrick SC, Kumar S, Morris SL. J Immunol; 2013 Nov 01; 191(9):4699-708. PubMed ID: 24078698 [Abstract] [Full Text] [Related]
12. Pre-existing Schistosoma japonicum infection alters the immune response to Plasmodium berghei infection in C57BL/6 mice. Wang ML, Cao YM, Luo EJ, Zhang Y, Guo YJ. Malar J; 2013 Sep 14; 12():322. PubMed ID: 24034228 [Abstract] [Full Text] [Related]
18. Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice. Liu Y, Chen Y, Li Z, Han Y, Sun Y, Wang Q, Liu B, Su Z. Eur J Immunol; 2013 Nov 14; 43(11):2907-18. PubMed ID: 23893352 [Abstract] [Full Text] [Related]